These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15569931)

  • 1. ErbB2 is required for ductal morphogenesis of the mammary gland.
    Jackson-Fisher AJ; Bellinger G; Ramabhadran R; Morris JK; Lee KF; Stern DF
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17138-43. PubMed ID: 15569931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ErbB3 is required for ductal morphogenesis in the mouse mammary gland.
    Jackson-Fisher AJ; Bellinger G; Breindel JL; Tavassoli FA; Booth CJ; Duong JK; Stern DF
    Breast Cancer Res; 2008; 10(6):R96. PubMed ID: 19019207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth.
    Andrechek ER; White D; Muller WJ
    Oncogene; 2005 Jan; 24(5):932-7. PubMed ID: 15580295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation.
    Jones FE; Stern DF
    Oncogene; 1999 Jun; 18(23):3481-90. PubMed ID: 10376526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
    Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
    Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal growth is impeded in mammary glands of C-neu transgenic mice.
    Mukherjee S; Louie SG; Campbell M; Esserman L; Shyamala G
    Oncogene; 2000 Dec; 19(52):5982-7. PubMed ID: 11146549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of cyclin D1 in concert with deregulated estrogen receptor alpha expression induces DNA damage response activation and interrupts mammary gland morphogenesis.
    Frech MS; Torre KM; Robinson GW; Furth PA
    Oncogene; 2008 May; 27(22):3186-93. PubMed ID: 18071314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
    Peng M; Ball-Kell SM; Tyner AL
    Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
    Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA
    Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RARα1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis.
    Cohn E; Ossowski L; Bertran S; Marzan C; Farias EF
    Breast Cancer Res; 2010; 12(5):R79. PubMed ID: 20923554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of eIF2alpha dephosphorylation inhibits ErbB2-induced deregulation of mammary acinar morphogenesis.
    Sequeira SJ; Wen HC; Avivar-Valderas A; Farias EF; Aguirre-Ghiso JA
    BMC Cell Biol; 2009 Sep; 10():64. PubMed ID: 19754954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammary gland development in transforming growth factor beta1 null mutant mice: systemic and epithelial effects.
    Ingman WV; Robertson SA
    Biol Reprod; 2008 Oct; 79(4):711-7. PubMed ID: 18614704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse mammary gland requires the actin-binding protein gelsolin for proper ductal morphogenesis.
    Crowley MR; Head KL; Kwiatkowski DJ; Asch HL; Asch BB
    Dev Biol; 2000 Sep; 225(2):407-23. PubMed ID: 10985859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
    Landis MD; Seachrist DD; Montañez-Wiscovich ME; Danielpour D; Keri RA
    Oncogene; 2005 Aug; 24(33):5173-90. PubMed ID: 15897883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of c-neu/ ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells: implications for breast cancer biology.
    Shyamala G; Chou YC; Cardiff RD; Vargis E
    Cancer Res; 2006 Nov; 66(21):10391-8. PubMed ID: 17079459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis.
    Sebastian J; Richards RG; Walker MP; Wiesen JF; Werb Z; Derynck R; Hom YK; Cunha GR; DiAugustine RP
    Cell Growth Differ; 1998 Sep; 9(9):777-85. PubMed ID: 9751121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin controls mammary gland development via direct and indirect mechanisms.
    Brisken C; Kaur S; Chavarria TE; Binart N; Sutherland RL; Weinberg RA; Kelly PA; Ormandy CJ
    Dev Biol; 1999 Jun; 210(1):96-106. PubMed ID: 10364430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive history determines Erbb2 locus amplification, WNT signalling and tumour phenotype in a murine breast cancer model.
    Ordonez LD; Melchor L; Greenow KR; Kendrick H; Tornillo G; Bradford J; Giles P; Smalley MJ
    Dis Model Mech; 2021 May; 14(5):. PubMed ID: 34003256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncoupling of PI3K from ErbB3 impairs mammary gland development but does not impact on ErbB2-induced mammary tumorigenesis.
    Lahlou H; Müller T; Sanguin-Gendreau V; Birchmeier C; Muller WJ
    Cancer Res; 2012 Jun; 72(12):3080-90. PubMed ID: 22665265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.